adminValcke, PSG boss in court
Paris Saint-Germain president Nasser Al-Khelaifi and FIFA’s former secretary general, Jerome Valcke, went on trial in Switzerland yesterday accused of corruption in the attribution of World Cup TV rights.
Dairy sector coming out of the woods
THE dairy sector’s performance from 2015 to the present seems to have laid a strong foundation for the argument that it is finally on a growth trajectory that will see it out of the woods after years of performing inconsistently.
Murape reveals 16-year secret
MURAPE MURAPE is back in the headlines and, for him, it’s time to reveal some of his best-kept secrets.
Face masks add to pollution woes
Since May 4 this year when it became mandatory for Zimbabweans to wear face masks in public spaces to limit the spread of the coronavirus disease (Covid-19), greater attention has been more on human survival than anything else.
Tongaat ramps up winter maize
Sugar producer Tongaat Huletts Zimbabwe has pledged to continue seed maize production at its estates in Chiredzi and Mwenezi with the firm also appealing for assistance to procure equipment for irrigating winter maize in the Lowveld, which straddles over 4 000 hectares.
Covid-19 impoverishes bartenders
Bartenders are struggling to make ends meet as they have been out of work since the alcohol ban recently imposed by the government.
Looking Back: Water problems blamed on delays in dam construction
The CHAIRPERSON of the Harare environment management committee Clr Herbert Gomba has proposed the holding of a water forum to discuss, among other key issues, the funding of water projects.
Neymar in race storm
Neymar was one of five players sent off after an injury-time brawl as Marseille beat Paris St-Germain 1-0 in a French Ligue 1 football match on Sunday.
5 factors that affect our COVID-19 vaccine response, according to this expert
The Oxford vaccine trial at the centre of safety concerns highlights the idea that people’s immune systems respond to vaccines differently.
Clinical trial for AstraZeneca Oxford COVID-19 vaccine candidate to resume
After the clinical trial for AZD1222 was halted last week, the studies for AstraZeneca’s COVID-19 vaccine candidate will now resume.